Enzyme-linked immunosorbent assay for Brucella melitensis-associated antigens

Area of Science:

• Immunology
• Infectious Diseases
• Medical Diagnostics

Background:

• Brucellosis is a significant zoonotic disease caused by Brucella species.
• Accurate and timely diagnosis of Brucellosis is crucial for effective treatment.
• Current diagnostic methods may have limitations in sensitivity or specificity.

Purpose of the Study:

• To develop and evaluate an Enzyme-Linked Immunosorbent Assay (ELISA) for detecting Brucella melitensis antigens directly in human blood.
• To assess the sensitivity and reproducibility of the developed ELISA assay.
• To compare the diagnostic utility of the ELISA assay in Brucellosis patients with and without ongoing therapy.

Main Methods:

• An indirect ELISA was developed using microtiter plates coated with rabbit anti-Brucella melitensis antibodies.
• Sera from Brucellosis patients and healthy controls were analyzed.
• Detection involved a secondary antibody conjugated to alkaline phosphatase and a specific enzyme substrate.
• Assay performance was evaluated using samples from patients undergoing and not undergoing therapy.

Main Results:

• All tested sera from Brucellosis patients not undergoing therapy showed significantly higher ELISA values compared to controls.
• A pool of 96 sera from normal subjects served as a negative control group.
• No significant difference in ELISA values was observed between Brucellosis patients undergoing therapy and those not undergoing therapy.
• The assay demonstrated reproducibility and sensitivity in detecting Brucella antigens.

Conclusions:

• The developed ELISA assay is a reproducible, sensitive, and suitable method for detecting Brucella antigens in the blood of Brucellosis patients.
• This ELISA test can serve as a valuable complementary tool to existing diagnostic methods for Brucellosis.
• The assay's effectiveness is demonstrated in patients irrespective of their therapeutic status, suggesting broad applicability.